The paper proposes a conceptual framework that medical therapies like beta-blockers improve heart failure outcomes by fundamentally improving the biological function of cardiac myocytes.
No takes yet. Share an insight, caveat, or question.
Supports beta-blocker use in HF via myocyte effects; leaves open prospective validation of this framework.
Bristow et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: